Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The maker of popular GLP-1 agonists Wegovy and Ozempic said technology from OpenAI, the company behind ChatGPT, will allow it to sift through and make sense of massive datasets to identify potential new uses for its diabetes and obesity treatments.
Chapter, a technology company based in New York City, said it tripled its revenue last year by filling a market niche designing technology for seniors—specifically, those who have questions about the Medicare program.
The publicly traded EHR and cloud healthcare IT infrastructure company confirmed in a filing with the U.S. Securities and Exchange Commission that hackers were able to breach its network in March for roughly eight hours, gaining partial access to patient record stores. The incident is being investigated.
The policy shift by Aetna to reimburse hospital stays of fewer than five days as outpatient observation encounters went into effect in January. The insurer implemented the policy to reduce friction with hospitals that previously had to seek approval for inpatient reimbursement, which was often denied. Jefferson Health is challenging the changes in court.
Comparing six dual-energy CT technologies marketed by three scanner manufacturers, radiology researchers have found all models helpful in determining the chemical composition of kidney stones even at substantially reduced radiation doses.
The Internet is an acceptable source of images for training algorithms to automatically triage patients with dislocated joints and similar orthopedic emergencies.
As FDA-approved AI software continues to proliferate in radiology—well more than 150 products to date and rising—a trio of Yale radiologists has compiled a status report focused on AI applications available to, specifically, emergency radiology.
AI can safely and accurately identify healthy breast tissue on ultrafast breast MRI, negating the need for a radiologist’s closer look and, in the process, lowering cancer screening costs and widening patient access to breast MRI.
Researchers have developed a novel cardiovascular MRI protocol as an option to the invasive gold standard, endomyocardial biopsy, for monitoring heart-transplant patients at risk of suffering organ rejection.
A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.